I have reviewed the specified inputs and produced a concise 1–2 page markdown note that links the 1000-gene panel to TME interpretation, provides example gene modules to score (exhaustion, cytotoxicity, IFN response, EMT, CAF, etc.), and explains how to read and apply the benchmarking outputs.

Saved file:
- /home/erwinpi/pantheon-agents/examples/gene_panel_selection/cases/gene_panel_selection_immune/workdir/biologist/final_biology_interpretation.md

Summary of key points in the note:
- Coverage across T cell, NK, B/plasma, myeloid, DC, neutrophil, mast, endothelial, fibroblast/CAF, and epithelial/malignant identities with state markers for activation, cytotoxicity, dysfunction, IFN response, antigen presentation, myeloid polarization, EMT, angiogenesis, and ECM remodeling.
- Practical module lists for scoring cytotoxicity, exhaustion/dysfunction, IFN response, MHC-II/APC activation, macrophage SPP1 program, CAF, endothelial activation, EMT/invasion, and more.
- Benchmark interpretation guidance:
  - Final panel is at the top or best across metrics: highest NMI, best (least negative) SI, competitive ARI with low variability.
  - UMAP similarity ~0.77–0.78 indicates strong preservation of whole-transcriptome neighborhood structure.
  - ARI vs panel size plateaus by 400–700 genes; 1000 genes sits on the performance plateau while maximizing biological breadth.
- Caveats: some canonical checkpoints (e.g., PDCD1/CTLA4/PD-L1) are not prominent; use included surrogates (TIGIT, LAG3, EOMES) and complementary IFN/chemokine context, and consider orthogonal protein/IHC where necessary.